# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001737287-24-000032
Filing Date
2024-04-23
Accepted
2024-04-23 16:31:45
Documents
38
Period of Report
2024-06-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | allo-20240423.htm iXBRL | DEF 14A | 742318
5 |  | allo-20240423_g1.jpg | GRAPHIC | 3079940
6 |  | allo-20240423_g10.jpg | GRAPHIC | 176786
7 |  | allo-20240423_g11.jpg | GRAPHIC | 199331
8 |  | allo-20240423_g12.jpg | GRAPHIC | 201263
9 |  | allo-20240423_g13.jpg | GRAPHIC | 172280
10 |  | allo-20240423_g14.jpg | GRAPHIC | 225443
11 |  | allo-20240423_g15.jpg | GRAPHIC | 226132
12 |  | allo-20240423_g16.jpg | GRAPHIC | 186553
13 |  | allo-20240423_g17.jpg | GRAPHIC | 249587
14 |  | allo-20240423_g18.jpg | GRAPHIC | 811159
15 |  | allo-20240423_g19.jpg | GRAPHIC | 563772
16 |  | allo-20240423_g2.jpg | GRAPHIC | 1018194
17 |  | allo-20240423_g20.jpg | GRAPHIC | 384343
18 |  | allo-20240423_g21.jpg | GRAPHIC | 200695
19 |  | allo-20240423_g22.jpg | GRAPHIC | 192244
20 |  | allo-20240423_g23.jpg | GRAPHIC | 1726704
21 |  | allo-20240423_g24.jpg | GRAPHIC | 2203673
22 |  | allo-20240423_g25.jpg | GRAPHIC | 924998
23 |  | allo-20240423_g3.jpg | GRAPHIC | 27990
24 |  | allo-20240423_g4.jpg | GRAPHIC | 6416
25 |  | allo-20240423_g5.jpg | GRAPHIC | 695051
26 |  | allo-20240423_g6.jpg | GRAPHIC | 214323
27 |  | allo-20240423_g7.jpg | GRAPHIC | 243677
28 |  | allo-20240423_g8.jpg | GRAPHIC | 195772
29 |  | allo-20240423_g9.jpg | GRAPHIC | 219934
| Complete submission text file | 0001737287-24-000032.txt |  | 32747676

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | allo-20240423.xsd | EX-101.SCH | 1881
3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | allo-20240423_lab.xml | EX-101.LAB | 2564
4 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | allo-20240423_pre.xml | EX-101.PRE | 1452
41 | EXTRACTED XBRL INSTANCE DOCUMENT | allo-20240423_htm.xml | XML | 54819

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38693 | Film No.: 24865252
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)